Embedded Files
Kim, Sue: VP of Corporate Marketing, ANAFLASH
Sue Kim is a seasoned marketing professional with over 25 years of experience in large enterprises and startups. She is based in Silicon Valley and has a proven track record in global marketing communications, corporate branding, digital marketing, public relations, and thought leadership programs. Her expertise spans startup marketing, public relations, strategic marketing planning, and international marketing strategies. In her current role as VP of Corporate Marketing at ANAFLASH, Sue enhances corporate visibility among key stakeholders and revitalizes branding elements to strengthen market presence. She has previously led high-impact marketing communications at Samsung Electronics, ams OSRAM Group, Marvell Semiconductor, Renesas, and The Hoffman Agency, spearheading successful marketing initiatives. As a marketing mentor for startups, Sue leverages her deep tech marketing expertise to guide emerging businesses toward sustainable growth, enhanced market presence, and increased investor interest.
(LinkedIn)
Kim, Kevin: Founder & CEO of BraveTurtles Inc.
Kevin majored in Digital Media at Otis College of Art and Design in Los Angeles. He has worked for 5 years in motion graphics, 2 years in CG (computer graphics) animation, and 5 years in film VFX (Visual Effects, special effects). While working in the VFX industry, he had the opportunity to work on Hugo, which won the 2012 VFX Oscar. In the same year, another project he worked on, The Game of Thrones, also received an Emmy for Outstanding Special Visual Effects. In 2016, with the goal of making his own game someday, Kevin joined a AAA game company, Respawn Entertainment, as a Sr. VFX Artist where he worked on Star Wars Jedi: Fallen Order in 2019. After 6 years of preparation, he finally decided to start his own business. In January 2021, Kevin founded the Metaverse game startup, Brave Turtles, Inc. (LinkedIn)
Jung, JiHee: Founder, Mediaiplus
Medical Science Representative, Roche
Medical Science Liaison, Mundipharma International Limited
Medical Science Liaison, Bayer
After being in the pharmaceutical industry for a decade, I realized the importance of clinical trials. But the process of getting started in clinical trials takes too long and costs too much, which results in delayed treatments for patients.
MediC provides customized solutions to clinical trials for bio-ventures to develop candidate substances.
Numerous worldwide bio-ventures, especially with imperfect infrastructure preparing clinical trials with help of CRO usually takes 15 months on average and consumes $75K. We try to shorten the amount of time and costs by providing global clinical trial information. We are committed to mediate between a bio-venture and CRO to operate clinical trials efficiently by collecting data and keeping them up-to-date.
So, I created Mediaiplus. If you're as passionate as I am about working on clinical trials, please get in touch! (LinkedIn)
Lee, Richard: CEO, Upccell, Inc.
With 15 years of experience in startups, including idea validation, planning, fundraising, team building, and revenue generation, I have developed a diverse range of expertise. Additionally, I have consulting experience in various business fields, including advising Korean medium and enterprise-sized companies entering the U.S. market.
Kim, Jung-Eun, MS, MotiForm
M.S. in biological sciences at Seoul National University.
B.S. in biology education at Seoul National University.
Senior researcher in LG household & healthcare.
Product owner in Ultracaption Inc.(merged to Kakao)
Venture capitalist in Donghoon Investment, etc.
Director of Custumor Success in Quotalab Inc.
Kang, Byoung Jo, Esq., CPA, Founder and President of B.J. Kang Law, PC
CEO of 901ers, Inc. with Notaryberry.com
Mr. Byoung Jo Kang is a business attorney with expertise in tax and accounting. Attorney Kang is admitted to practice law in VA, MD, CA, US Tax Court and US District Court Eastern District of Virginia, and he is also a VA licensed CPA. Before coming to the U.S., Mr. Kang was a Ph.D. Student at Seoul National University focusing on late 19th Century Korean literature. After getting his M.A. degree at Harvard University (2002), Mr. Kang pursued his professional career in accounting/taxes and progressed his career from entry-level accountant to executive in well-known organizations. Based on his expertise in accounting/taxes, Mr. Kang regularly represents high net-worth U.S. and foreign individuals and families, and multinational companies. Ever since he set up one of the first online education companies in Korea in 2000, Mr. Kang has never stopped actively engaging in various entrepreneurial efforts. After concluding his role as the Board Director of NeoImmunetech, Inc for five years (2019-2024), he currently serves as the CEO of 901ers, Inc., which successfully launched the online remote notarization platform, NotaryBerry.com.
Kim, Greg (Kwangrok): Partner & Co-Founder, Sazze Partners
Kwangrog is a co-founder and managing partner at Sazze Partners. Since 2018, Primer Sazze Partners has been dedicated to investing in exceptional Korean founders, with the mission of supporting the next generation of entrepreneurs in South Korea and globally. Before this, Kwangrog co-founded Sazze Partners in 2014, focusing on transformative consumer tech companies. In 2005, he co-founded Sazze, Inc., a holding company for fast-growing e-commerce startups. (LinkedIn)
Se-Hwang Kim, Mus.D.
General Director of Entertainment at Hanchang Corporation
SeHwang Kim, Mus.D. is a world-renowned guitarist and artist to be inducted into the RockWalk of Fame in Hollywood. With over 25 years of experience in the global music, entertainment, startup and tech industries, he served as as managing partner and judge for investments at various organizations and as a judge for 2025 CES Innovation Awards. He is currently the General Director of Entertainment at Hanchang Corporation leading the expansion of global business in entertainment and technology including the recent acquisition of K-Pop label, Beat Interactive (artists: FORESTELLA, NEWBEAT). He is also a lecturer and performer at NASA-JPL and UCLA.
Peter Bae, CEO, Korean Innovation Center @ Silicon Valley.
Peter Bae is the CEO for the Korean Innovation Center @ Silicon Valley. KIC Silicon Valley supports startups launching their products and services in North America through acceleration programs, industry expertise and capital networks. Peter is himself a four-time founder of startups notably Social Radio Company, Alcacruz, Fantage and Anoxis, and a prolific advisor and investor to more than a two dozen of Korean startups.
Charlie Kim, Principal, KDB Silicon Valley
Charlie Kim is a Principal at KDB Silicon Valley, where he partners with bold founders building technologies that transform global industries. His investment focus spans AI, robotics, and biotechnology, with a keen interest in early-stage companies tackling foundational problems with long-term vision. Before joining KDB, Charlie was at Deloitte, advising large-cap technology companies on cross-border strategy and transfer pricing. With a background in Economics and Mathematics from Emory University, and global experience across Korea and the U.S., Charlie brings both analytical depth and cultural fluency to every partnership.
Siyeon Rhee, Instructor, Stanford University, Co-founder & Representative Committee Member, K-bioX
Siyeon is an instructor at Stanford University and a co-founder and representative committee member of K-BioX, one of the largest global nonprofit communities connecting life scientists, clinicians, and biotech entrepreneurs across the U.S. and Korea. At Stanford, he leads research in developmental and cardiovascular biology, specializing in advanced single-cell and spatial transcriptomic technologies. Through K-BioX, he has organized numerous international summits, mentorship programs, and startup accelerators to empower early-career scientists and foster biomedical innovation. Siyeon actively serves as a judge, advisor, and bridge-builder between academia and industry in the life sciences ecosystem.
Eunbi Cho, Product Madager, Silver Rain
Eunbi Cho is an experienced product manager with a strong multidisciplinary background in e-commerce, product development, UX design, and creative direction. With over 15 years of experience across industries including tech, entertainment, fashion, and retail, she has built a career around connecting brands with communities through thoughtful, user-centered strategies. Her work bridges both creative and operational functions, enabling her to oversee projects from concept to execution while collaborating across teams and cultures. Eunbi is especially passionate about creating meaningful customer experiences and bringing fan and user perspectives into every stage of the product lifecycle. She has also played an active role in community engagement and leadership, currently serving as Co-President of SoCal K-Group, a nonprofit supporting Korean American professionals in tech. With a deep appreciation for culture and storytelling, Eunbi continues to explore new ways to align product strategy with authentic community connection. Outside of work, she enjoys crafts, anime, and games, and brings the same curiosity and creativity to her personal passions as she does to her professional life.
Jennifer Cho, PhD, Partner, Solaris Venture Partners
Jennifer Cho, Ph.D. is a physicist-turned tech business strategist with over 15 years of industry experience across healthcare, energy and batteries, logistics tech, and culturally driven consumer products. She has held leadership roles such as President of Portlogics USA, where she revolutionized global trade through digital forwarding, and currently serves as a Venture Partner at Solaris Venture Partners, focusing on growth-stage opportunities in AI, robotics, data centers, and digital infrastructure. Dr. Cho earned her Ph.D. in Biomedical Physics from UCLA and has led product development, go-to-market strategy, and global expansion efforts at various technology startups, including Soundable Health, Millibatt, Encored Technologies, MILabs, and Sofie Biosciences. Known for her sharp analytical thinking, systematic approach, and excellent communication skills, Jennifer emphasizes team-driven success and structured execution, guided by a results-oriented work ethic.
BonggunShin, PhD, Executive Director, Head of AI/DT TF, SK Life Sceince
Dr. Shin is deeply passionate about fostering innovation by bridging AI with diverse domains, notably biotechnology and novel drug development. He earned his Ph.D. in Computer Science from Emory University, where he received the prestigious Graduate Student Research Award. His doctoral research encompassed Natural Language Processing (NLP), healthcare solutions, and pharmaceutical development. During this period, he co-founded Deargen, an AI-driven drug development company, playing a pivotal role in securing Series A and B funding rounds. The company's significant achievements included accurately predicting drug efficacies for COVID-19, demonstrating their advanced technological capabilities, culminating in a successful acquisition by Amyloid Solution after the completion of their Series B funding. At SK Biopharmaceuticals, Dr.Shin currently leads AI transformation initiatives across the entire drug development lifecycle, driving substantial advancements in pharmaceutical innovation. Throughout his career, he has published numerous influential papers and holds over ten patents.
Page updated
Report abuse